Loading clinical trials...
Loading clinical trials...
Immunoglobulin-specific Prophylaxis Against Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Conditions
Interventions
Anti-CMV immunoglobulins [Megalotect (R)]
Locations
1
Italy
IRCCS Burlo Garofolo
Trieste, Italy
Start Date
June 2, 2025
Primary Completion Date
December 31, 2025
Completion Date
June 2, 2026
Last Updated
June 10, 2025
NCT07101588
NCT06093867
NCT07294547
NCT05534620
NCT06926894
NCT05626530
Lead Sponsor
Antonello Di Paolo, M.D., Ph.D.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions